Table: begin end state 1 21 cytoplasmic 22 44 transmembrane 45 55 non-cytoplasmic 56 76 transmembrane 77 87 cytoplasmic 88 106 transmembrane 107 113 non-cytoplasmic 114 134 transmembrane 135 145 cytoplasmic 146 170 transmembrane 171 176 non-cytoplasmic 177 202 transmembrane 203 254 cytoplasmic 255 275 transmembrane 276 286 non-cytoplasmic 287 310 transmembrane 311 317 cytoplasmic 318 336 transmembrane 337 341 non-cytoplasmic 342 365 transmembrane 366 383 cytoplasmic 384 404 transmembrane 405 409 non-cytoplasmic 410 431 transmembrane 432 447 cytoplasmic
Input: >AO353_14270 MRTIDVHEVIDNARFNRFHWRVLCWCALIIIFDGYDLVIYGVVLPMLMKDWGLSPLQAGA LGSYALFGMMFGALFFGPLSDRIGRKKAITLCVMLFSGFTVLNGFAGNPTEFGICRFIAG LGIGGVMPNVVALMNEYAPKKIRSTLVAIMFSGYSVGGMLSAGLGIVLIPSFGWQSVFYV AIVPLLLLPLIMCFLPESVGFMLRQGRNEQARKVLQRVDPAYVAQATDQLHMTEVKGSGT PVLQLFREGRAMRTLMLWLAFFCCLLTVYALSSWLPKLMANAGYSLGSSLSFLLVLNFGA IFGAVGGGVLGDKLNLPRVLAVFFSIAAVSITLLGFNSPTPVLYLLIAIAGATTIGSQIL LYACAAQFYSMAIRSTGLGWASGIGRNGAIVGPLLGGALLGISLPLQLNFMAFALPGAIA AIAMAVFAISCQRSSKGVASRLVPTSV
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server